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ATTITUDES TOWARD AND UPTAKE OF PRENATAL GENETIC SCREENING 
AND TESTING IN TWIN PREGNANCIES 
 
Kathryn M. Reese, BS 
Advisory professor: Claire Singletary, MS 
The rate of twinning is rising and is associated with delayed age at 
childbirth and increased infertility treatments. Since the introduction of non-
invasive prenatal testing, interest in and uptake of genetic screening and testing in 
twin pregnancies has not been investigated. Therefore, this study aimed to describe 
the attitudes toward and uptake of current prenatal genetic screening and testing 
options in twin pregnancies. Forty-two women with twin gestations were recruited 
from UTHealth and Baylor College of Medicine sites between August 2016 and 
January 2017 for participation in a descriptive study consisting of a questionnaire 
(n=42) and semi-structured phone interview (n=15). Descriptive statistics and 
Fischer’s exact-test were employed for questionnaire analysis. Qualitative data 
from interviews were analyzed using grounded-theory to identify common themes. 
Data analysis showed that women were significantly more in favor of screening 
than diagnostic testing (p = 0.049).  Sixty-nine percent elected genetic screening, 
while only three percent had a diagnostic procedure. Women were interested in 
screening for preparation or reassurance despite having concerns about accuracy 
and uncertainty associated with screening in twin pregnancies. Most women (86%) 
felt they would make the same decision if it were a singleton pregnancy, 
suggesting that twin pregnancy may not impact decision-making for many women. 
Despite this, 48% of women still cited being pregnant with twins as an influencing 
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factor. Information learned from medical providers, past experiences, and family 
and friends were also cited as influencing factors, suggesting that tailoring 
prenatal genetic counseling sessions for twin gestations might parallel that of 
singletons. Although it did not alter patient decisions for 91% of women, genetic 
counseling was used as a platform to raise concerns and gather information. No 
significant differences between natural and assisted conception patients were 
found; however, further research in this area is necessary given the small sample 
size. 
 
		
	 	v		
TABLE OF CONTENTS 
Approval Page…………………………………………………..……………………….Page i 
Title Page……………………………………………………….……...………………..Page ii 
Abstract…………………………………………………………………………………Page iii 
Table of Contents………………………………………………………………………..Page v 
List of Tables and Figures………………………………………………………………Page vi 
Introduction……………………………………………………………………………...Page 1 
Materials and Methods…………………………………………………………………..Page 3 
Results…………………………………………………………………………………...Page 5 
Discussion……………………………………………………………………………...Page 16 
Conclusion………………...……………………………………………………………Page 20 
Bibliography……………………………………………………………………………Page 21 
Appendix A…………...………………………………………………………………..Page 23 
Appendix B…………………………………………………………………………….Page 24 
Vita……………………………………………………………………………….....….Page 25 
  
		 	vi			
LIST OF TABLES AND FIGURES 
 
Table I. Demographic Characteristics…….…..………………………………………....Page 7 
Figure 1. Attitudes toward screening vs. diagnostic testing…………………………......Page 8 
Table II. Interest in Prenatal Genetic Screening and/or Testing……………………….Page 10 
Table III. Concerns about Prenatal Genetic Screening and/or Testing...…….…….......Page 12 
Table IV. Factors influencing decision-making …......……....………………………...Page 14 
Figure 2. Uptake Flowchart………………………….…………………………………Page 15 
Figure 3. Influence of twin pregnancy on uptake………………………..…………….Page 16 
 
 
  
		
	 	1		
INTRODUCTION 
Genetic counselors may become involved in the prenatal care of women carrying twins 
due to delayed childbirth and subsequent advanced maternal age (AMA) among other 
indications. AMA is a common referral for prenatal genetic counseling and is defined as a 
woman who will be 35 years or older at the time of delivery in a singleton pregnancy. 
However, many clinicians use 31 or 33 years or older as AMA for twin pregnancies due to 
the comparable risk for aneuploidy in at least one fetus (1).  
According to data from the U.S. Department of Health and Human Services, the twin 
birth rate was 33.9 per 1,000 births in 2014. This rate rose 76% from 1980 to 2009 and then 
rose an additional two percent by 2013. Increasing twin birth rates have been associated with 
trends of delayed age at childbirth and increased use and availability of infertility treatments 
compared to previous decades (2). The American Society for Reproductive Medicine 
(ASRM) defines assisted reproductive technology (ART) as treatments and procedures 
involving the handling of human oocytes and sperm, or embryos, with the intent of 
establishing pregnancy (3). ART has been used in the US since 1981 and today, 1% of all 
infants born are conceived using ART. Women who undergo ART procedures are more 
likely to have multiple gestations than women who conceive naturally. 
The psychosocial impact of infertility and ART has been linked to distress, loss of 
control, stigmatization, and a feeling of disruption in the way women viewed their life to go 
(4). Some stressors experienced include infertility itself, inconvenience associated with 
treatment, perception of a low success rate, time spent waiting for results, as well as financial 
pressure (5).  
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Whether conceived naturally or through ART, once women achieve a pregnancy, they are 
faced with decisions about screening and testing. Genetic counselors often act as facilitators 
for decision making about prenatal genetic screening, such as first trimester screen, 
quadruple screen, or non invasive prenatal testing (NIPT) and diagnostic testing. This is 
complicated in twin pregnancies because there is relatively little literature on aneuploidy 
screening in twin pregnancies and conclusions are inconsistent. Detection rates for Down 
syndrome when using first trimester nuchal translucency (NT) measurement and maternal 
age are 70-88% in twin pregnancies, which is similar to that in singleton pregnancies (6). The 
Down syndrome detection rate of a quadruple marker serum screen is 51-63% (7) compared 
to 81% in singleton pregnancies (8). Diagnostic testing via chorionic villus sampling (CVS) 
and amniocentesis is also available. The risks with CVS appear to be relatively comparable 
between singletons and twins. However, the risk for miscarriage after amniocentesis appears 
higher for twin gestations compared to singletons (9).  
In 2011, NIPT became clinically available, providing more prenatal screening options for 
high-risk pregnancies. NIPT using massively parallel shotgun sequencing (MPSS) 
technology can be applied to twin gestations and screens for trisomy 21, trisomy 18, trisomy 
13, and the presence of the Y chromosome. While detection rate varies by testing laboratory, 
a meta-analysis in 2015 found a detection rate of 93.7% for trisomy 21 in twin pregnancies 
and a false positive rate of 0.23% (10).  
Prior to the availability of NIPT as a screening option, a studied cohort of 343 twin or 
higher or multiple pregnancies and found a minority (23%) of patients elected to undergo 
prenatal genetic screening or testing (11). The authors found that 94% of the patients who did 
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have prenatal genetic screening or testing chose maternal serum screening. It was 
hypothesized that it may be viewed as less risky than the alternatives while still relieving 
some anxiety. Furthermore, no relationship was found between the use of ovulation induction 
(OI) or ART and election of prenatal genetic testing (11, 12). However, these studies predate 
NIPT, a screen with higher sensitivity and specificity. Therefore, this study aimed to describe 
the uptake of and attitude toward current prenatal genetic screening and testing options in 
twin pregnancies in order to provide insight into the factors that play a role in the choice to 
undergo genetic screening or testing.  
MATERIALS AND METHODS 
Study Design 
Women having genetic counseling at one of six McGovern Medical School at 
UTHealth, Department of Obstetrics, Gynecology and Reproductive Sciences, Division of 
Maternal Fetal Medicine affiliated clinics or one of seven Baylor College of Medicine, 
Department of Obstetrics and Gynecology affiliated high-risk pregnancy clinics were 
recruited between August 2016 and January 2017. Eligible women included those who were 
pregnant with twins, age 18 or older, and English speaking who were seen for prenatal 
genetic counseling in their current pregnancy. Exclusion criteria included women under the 
age of 18, singleton pregnancies, non-English speakers, and twin pregnancies seen in the 
high-risk fetal center with anomalies excluded at the discretion of the genetic counselor. 
Eligible women were given a letter of invitation by the genetic counselor at the 
conclusion of the genetic counseling appointment.  Participants could consent to either the 
anonymous survey only or the anonymous survey and an additional phone interview. Semi-
structured interviews were conducted by the study coordinator (KR) via telephone with 
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participants who indicated interest and provided contact information. Transcription by the 
interviewer was performed by listening to recorded audiotapes and transcribing everything 
spoken by the interviewer and study participant into a protected document. 
The institutional review boards at the University of Texas Health Science Center at 
Houston (HSC-MS-16-0410) and Baylor College of Medicine (H-39711) approved the study 
protocol. 
Data Collection 
 Data were collected through in person questionnaires collected immediately 
following the genetic counseling appointment and via semi-structured telephone interviews 
within eight weeks of the appointment. The survey collected information about attitudes 
toward prenatal genetic screening and testing, changes related to the genetic counseling 
appointment and impact of twin pregnancy on decision-making from participants. 
Demographic information including age, gravidity and parity, indication for genetic 
counseling, use of ART, genetic screening/testing offered, and genetic screening/testing 
accepted was recorded by the genetic counselor (Appendix A). The telephone interviews 
were conducted by the study coordinator (KR) using an interview guide (Appendix B) and 
lasted approximately 20 minutes. The telephone interviews were audio taped and transcribed 
by the interviewer. The study questionnaire and interview guide were created by the authors 
and were not formally validated.   
Data Analysis 
Questionnaire data were entered into a secure Microsoft Excel file and STATA 
software version 13.1 was used for statistical analysis of quantitative data. Categorical 
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variable data were reported as frequencies and percentages and analyzed using two-sample t-
test and Fischer’s exact test. Transcripts were entered into ATLAS.ti version 1.0.50. 
Thematic analysis was used to identify major themes in the responses, using the grounded 
theory approach. Each transcript was coded and grouped into categories that revealed similar 
themes. The study coordinator (KR) and one author (CS) independently analyzed three 
transcripts to compare and establish consistency in coding using a preliminary codebook. An 
inter-coder concordance of 80% was achieved. KR analyzed the remaining transcripts and 
grouped responses into themes. 
RESULTS 
 A total of 42 individuals participated in the study. Of those, 27 (64%) consented to 
participate in the phone interview in addition to the questionnaire, while 15 (36%) consented 
to the questionnaire only. Of the 27 who indicated willingness to participate in the phone 
interview portion, there were 16 (59%) individuals who completed the interview and 11 
(41%) that could not be reached after multiple attempts. One completed interview was 
excluded from analysis due to fragmented recording. The average age of study participants 
was 31 years, with a range from 21 to 47 years old, and the majority were Caucasian (Table 
I). The majority of participants were multigravida with the most common indications being 
AMA (43%) and low risk (38%). Participants were recruited from Houston-area University 
of Texas Health Science Center at Houston (UTHealth) and Baylor College of Medicine 
(Baylor) affiliated clinics. Eleven participants were from UTHealth clinics and 31 were from 
Baylor clinics, representing 30% of eligible UTHealth patients (11/37) and 78% of eligible 
Baylor patients (31/40) seen for prenatal genetic counseling during the survey collection 
period. No significant differences in demographic distribution were found between 
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participants from the UTHealth and Baylor sites (p > 0.05), (Table I). Additionally, 
demographic distribution of the study sample was not significantly different between those 
who were interviewed and those that only answered the questionnaire (p > 0.05), (Table I).   
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*Data missing for 2 participants from Baylor clinics 
**All p-values > 0.05 for comparison of UTHealth and Baylor demographics 
***All p-values > 0.05 for comparison of interview and survey only demographics 
  
Table I. Demographic characteristics of study participants (n=42) 
Characteristic Baylor** (n=31) 
UTHealth** 
(n=11) 
Interview & 
Survey*** 
(n=15) 
Survey 
Only*** 
(n=27) 
Mean Age (years) 31.35 31.27 30.4 31.9      Total SD = 5.6 
 n % n % n % n % 
Ethnicity 
     Caucasian 14 45% 5 46% 7 47% 12 44% 
     Hispanic 5 26% 3 27% 4 27% 4 15% 
     African American 8 16% 1 9% 2 13% 7 26% 
     Asian 4 13% 1 9% 1 7% 4 15% 
     Other 0 0% 1 9% 1 7% 0 0% 
         
Indication         
     Low Risk 11 35% 5 45% 8 53% 8 30% 
     AMA 12 39% 6 55% 5 33% 13 48% 
     Positive Family History  1 3% 0 0% 0 0% 1 4% 
     US Abnormality 3 10% 0 0% 1 7% 2 7% 
     Multiple 4 13% 0 0% 1 7% 3 11% 
         
Gravidity*         
     Primigravida 9 29% 2 18% 5 33% 6 22% 
     Multigravida 20 65% 9 82% 9 60% 20 74% 
         
Mode of Conception         
     Natural 23 74% 4 64% 12 80% 4 64% 
     Assisted  8 26% 7 36% 3 20% 7 36% 
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Attitude toward prenatal genetic screening and testing 
 
 Multiple attitudes toward screening and testing were identified. Women carrying twin 
pregnancies were found to be significantly more likely to be “in favor of” or “strongly in 
favor of” prenatal genetic screening compared to prenatal diagnostic testing (p = 0.049), 
(Figure 1).   
 
Figure 1. Attitudes toward screening vs. diagnostic testing 
 
Comparing attitudes of those with a natural conception to those with assisted 
conception revealed no significant difference between the groups (p > 0.05). In general, both 
groups were more in favor of screening than diagnostic testing, with 80% of those with a 
natural conception and 92% of those with assisted conception feeling “in favor of” or 
“strongly in favor of” prenatal genetic screening. Indication for genetic counseling referral 
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was not found to have a significant influence on attitude toward prenatal genetic screening or 
testing (p > 0.05 across indications). 
Interest in prenatal genetic screening and/or testing 
 Interview respondents reported an overall general interest in prenatal genetic 
screening and/or testing. Motivations for this interest varied among responses, with the risk 
of possible abnormalities in the pregnancy being the most commonly used code. One woman 
indicated “[she’s] always scared that [the test] will come back that [they’re] carriers of 
something or [their] risk is higher for something” but that “it’s always better to know”.   
The next most common motivation for interest in prenatal genetic testing was a desire 
for answers in order to be better prepared, reassured, or have peace of mind. Forty-eight 
percent of participants selected gaining reassurance about the pregnancy as an influencing 
factor in the questionnaire. Participants felt that “it’s one of those things where [they] would 
like to be prepared if something was to happen” and that “with twins… [they] need to know 
what’s going on as much as possible”. Additional examples of interest in prenatal genetic 
screening and/or testing can be found in Table II. 
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Table II. Interest in prenatal genetic screening and/or testing 
Themes Responses 
Concern for Possible 
Abnormalities (n=19) “… like any other woman I was scared that...something would be found “  
“I’m a little bit more worried about having children after 
the age of 34... because of seeing that scale and those 
percentages of…the baby being affected with the 
different types of chromosome [conditions]” 
Wanting Answers (n=9) “… is there a way for us to find out if we’re going to 
have a healthy baby or if both babies are going to be 
healthy? Then we want to go ahead and do a 
prescreening.“ 
Preparation (n=7) “I think it’s important to know everything you can before 
going into it” 
Reassurance (n=6) “I would have done it anyways just to kind of make sure 
there weren’t any problems 
“I just wanted to make sure there wasn’t anything that I 
need to be worried about as far as like you know the 
health of the baby” 
Peace of Mind (n=3) “[genetic testing] does have such an ability to bring peace 
of mind or to… help parents…plan… get a better idea of 
what…they’re walking into” 
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Concerns about prenatal genetic screening and/or testing 
Respondents also expressed concerns about prenatal genetic screening and/or testing. 
In some cases, these concerns were strong enough to make the woman not interested in 
screening or testing. The most common concern was for the risks posed to the pregnancy as 
one woman expressed in her statement “I would’ve rather not taken that risk of losing them 
than trying to figure out if something was wrong with them”.  An interview with a woman 
who conceived via IVF revealed substantial concern about invasive testing due to associated 
risks. She said that she felt she “worried more about loss… than if [conception] had 
happened easily” and that she knew “it’s not going to be easy… if [they] needed to start 
over”. Additional concerns included cost, anxiety, uncertainty, and accuracy of screening 
(Table III). 
Overall, codes associated with concern about prenatal genetic screening and/or testing 
were used more frequently (n = 171) than codes associated with interest in prenatal genetic 
screening and/or testing (n = 99).  
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Table III. Concerns about prenatal genetic screening and/or testing  
Themes Responses 
Risks to Pregnancy (n=19) “… invasive stuff comes with risks…I definitely didn’t 
really want to do those unless there was…a high, high 
risk of some abnormalities“ 
“… but as far as the other options, [FTS] felt like safer, 
like a safer option” 
“I would’ve rather not taken that risk on losing them then 
trying to figure out if something was wrong with them” 
Cost (n=16) “… with the cost involved, I wouldn’t have done it even 
for one [baby]” 
“I had some friends say no don’t do it it’s kind of a waste 
of money.” 
“But it wasn’t covered by my insurance and I’m already 
paying a lot” 
“If money wasn’t something that was obviously sitting 
there staring me right in the face… we would have 
absolutely gone ahead with the genetic testing.” 
Fear and Anxiety (n=18) “I had a lot of anxiety about the pregnancy as it is… 
testing is… another thing to be anxious about.” 
”I was actually pretty scared and nervous.“ 
Uncertainty (n=9) “I think with fraternal, I’d always wonder… which twin it 
came from and…worry about it that way” 
“… we didn’t know really what the sort of accuracy rates 
were… or many of the specifics of… how the 
information, how the results are delivered” 
Concern about Accuracy 
(n=10) “… it sounds like the accuracy is higher with just one baby than it is with two. So I think then we might have 
been more willing to do it” 
“…if there was only one we might have been more open 
to it but since there was two… and the accuracy is not as 
high, we were less inclined” 
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Factors influencing decision-making 
Respondents indicated that information gathering was an important factor in decision-
making (n = 46) both from information they learned in the genetic counseling session and 
outside of the session. For example, one woman said that “if anything, [the genetic 
counselor] gave [them] information to actually formulate opinions.” 
Experiences in previous pregnancies and experiences of friends and family members 
were cited as influencing factors (n = 37). One woman said, “it’s one of those things… 
[they’ve] historically done just the… standard first trimester screen”.  Additionally, 
input of support persons such as partners or spouses played a role in women’s decision-
making. One woman said that she and her husband “weighed out the pros and cons” and that 
he was a “major factor in it… and helped decide if [they] were going to do it or not”. Two of 
the most common factors selected in the questionnaire as having influenced participant’s 
decisions included being pregnant with twins (48%) and their partner/spouse (43%). 
Additional examples of factors influencing decision-making can be found in Table IV. 
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Table IV. Factors influencing decision-making  
Themes Responses 
Information Gathering (n=46) “… they just wanted to let me be aware of… there’s a 
99% chance, sure that there is nothing wrong with them” 
“I felt more aware, I got more… information I guess. I 
got more aware of what possibilities of what could be 
happening” 
“I would say that the only thing that the counselor kind of 
affected for was like looking at those charts and seeing… 
the percentage of risk based on the age” 
“… she broke everything down, you know, and 
explained… all of our options” 
Prior Experience and 
Knowledge (n=37) “… the test that we chose and doing that with my last son, him being perfectly fine then I was pretty much at 
ease with doing the same test” 
“… my cousin got the [amniocentesis]… she wanted to 
know and she ended up losing her kids cause of the 
infection” 
“I was seen by the same doctor with… all my three 
children… But I was never offered… so I didn’t even 
know you had those kind of testing” 
Support Persons (n = 2) “… my husband. I asked him what he thought and he said 
yeah let’s just do the same test we did with my son” 
“… my mom… went with me… she was the one who… 
guided me in the decision making process.” 
“… my mom said that she never got any of that testing 
done but I just don’t think it was available at the time. I 
don’t know what she would have done now.” 
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Uptake of prenatal genetic screening and testing 
There was no significant difference in uptake of prenatal genetic screening and testing 
between natural and assisted conception women (p = 0.48). When asked about whether or not 
their decision about prenatal genetic screening or testing agreed with their feelings prior to 
the genetic counseling appointment, 91% answered that it did agree. Additionally, 86% of 
women answered that their decision about prenatal genetic screening and testing would have 
been the same if it were a singleton pregnancy. Of the 41 women offered a prenatal genetic 
screening or diagnostic test, 39% declined all testing. Of the 36 women offered prenatal 
genetic screening (first trimester screen, quadruple screen, NIPT), 69% accepted. Of the 39 
women offered diagnostic genetic testing (chorionic villus sampling, amniocentesis), one 
individual accepted (Figure 2). 
 
Figure 2. Uptake Flowchart 
  
Individuals who accepted a screening test had attitudes that were generally more 
“strongly in favor of” screening (56%) compared to those that declined screening tests 
(18%); however, the overall difference in attitudes was not significant (p = 0.053). Those 
41 offered 
36 offered 
genetic 
screening 
25 accepted 
(69%) 
 11 declined 
(31%) 
39 offered 
diagnostic 
testing 
1 accepted (3%) 
 38 declined 
(97%) 
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who accepted a prenatal genetic screening test were significantly more likely to say that they 
would make the same decision if it were a singleton pregnancy (p = 0.030), (Figure 3). All 
four of the women who indicated that they would make a different decision about prenatal 
genetic screening or testing in the pregnancy if it were a singleton were also a part of the 
48% of women who selected being pregnant with twins as having influenced decisions.  
 
Figure 3. Influence of twin pregnancy on screening uptake 
 
 DISCUSSION 
 To our knowledge, this is the first study exploring the attitudes toward and uptake of 
prenatal genetic screening and testing in twin gestations since the advent of NIPT. As 
anticipated from increasing trends toward screening in singleton pregnancies since the 
introduction of NIPT, we found that women carrying twins were more likely to be in favor of 
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prenatal genetic screening compared to diagnostic testing (13). The risk of diagnostic testing 
appeared to be a deterrent for some, as seen in previous studies (14). Women communicated 
a desire to have answers to be better prepared or for reassurance. Attitudes did not differ 
depending on whether women conceived twin pregnancies naturally or through assisted 
conception methods. Despite participants being in favor of screening, concerns and barriers 
were more frequently discussed than interest. In these cases, genetic counseling was used as a 
platform to relay these concerns and gather additional information about screening and 
testing, empowering women to make a decision. It appears as though the genetic counseling 
process made women feel more comfortable with their decision rather than altering it, 
although future research is needed to capture both pre and post counseling feelings in order 
to confirm this finding. 
Our cohort did elect to undergo screening or testing more often (61%) than a 2006 cohort 
of 343 twin or higher or multiple pregnancies (23%), (11). It is possible that this difference 
can be explained by the availability of NIPT, since the higher detection rate and lower false 
positive rate compared to older screens may have lessened concerns. Given that detection 
rates are even higher in singletons, those who elected to undergo screening might have done 
so regardless of twin gestation.  
The majority of women said they would make the same decision if they had a singleton 
pregnancy, suggesting that having twins was not an influencing factor. This finding is 
contradictory to the finding that “being pregnant with twins” was the most commonly cited 
factor in interviews influencing their decision-making. Perhaps those that did not uptake any 
screening or testing were more influenced by twin pregnancy. In fact, the women who 
indicated that they would make a different decision about prenatal genetic screening or 
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testing in the pregnancy if it were a singleton were a part of the 48% of women who selected 
being pregnant with twins as having influenced decisions. They may have recognized an 
additional layer of complexity involved in screening and testing for twins. Genetic 
counselors have the skill set to uncover which women are concerned about this complexity, 
encourage discussion, and assist in decision-making.  
The process of genetic counseling did not appear to ultimately change decisions about 
prenatal genetic screening and testing for most women, although interview responses 
indicated that patients do find it helpful and informative. Information gathering about genetic 
screening and testing takes place in multiple settings, including medical appointments, past 
personal experience, and the experiences of family and friends. It is possible that anchoring, 
the concept that people’s decisions are most influenced by their initial experiences and 
knowledge, can explain the why the majority of women reported that genetic counseling did 
not change their initial impression of genetic screening and testing (15). The anchoring 
heuristic has been previously explored in genetic counseling decision-making, with positive 
attitude towards genetic testing being one of the determining factors predicting intent to 
undergo testing (16). While patients say they are open to learning more information, anchors 
appear to play an important role in prenatal genetic counseling.  
Practice Implications 
This study provides insight into the attitudes toward prenatal genetic screening and 
testing in women carrying twin pregnancies in an effort to assist in the tailoring of sessions 
for this patient population. Data suggest that tailoring sessions for twin gestations might 
parallel that of singletons. Anticipating concerns about risks, cost, uncertainty, and 
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accuracy surrounding testing options might make facilitation of decision-making easier 
and uncover those patients for whom the complexity alters their decision. However, it is 
not likely to change the majority of patient’s attitudes set by personal anchors.   
Study Limitations 
The small sample size was a major limitation of the current study, as this impacted 
the ability to make comparisons between those with natural and assisted conceptions in the 
interview portion. A longer recruitment time frame might increase sample size enough to 
achieve statistical significance. Another limitation was the limited demographic information 
collected, as the influence of socioeconomic status, education level, or religious affiliation on 
decision-making could not be explored.  
Of note, the interviews did not take place at the same duration after the genetic 
counseling appointment for all participants. Some individuals could not be reached for over a 
month, and it is possible that the length of time since the genetic counseling appointment 
altered their attitude and responses. In addition, participants who had stronger attitudes 
toward prenatal genetic screening and testing may have felt compelled to share their 
perspectives and thus led to an ascertainment bias. 
Future Directions 
 Additional studies with larger cohorts should be undertaken in order to determine if 
there are in fact differences between the natural and assisted conception groups on qualitative 
section of the questionnaire. In addition, including a singleton matched comparison group 
could provide more insight into potential differences.  
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CONCLUSION 
The majority of women with twin gestations were in favor of and opted into prenatal 
genetic screening, despite expressing concerns. Most did not feel that their decision would 
vary if they had been carrying a singleton, suggesting that tailoring genetic counseling for 
twin gestations might be similar to that of singletons. Genetic counselors have the skill set 
to uncover which women belong to the minority who are concerned about the complexity of 
screening in twins and to assist in decision-making.  
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APPENDIX A. 
 
1. How do you feel about prenatal genetic screening (first trimester screening, quad screening, NIPT, 
cell-free DNA) in your current pregnancy? 
 
Strongly against        Strongly in favor of 
1   2   3   4  5 
 
2. How do you feel about prenatal genetic testing (chorionic villus sampling-CVS, amniocentesis) in your 
current pregnancy? 
 
Strongly against        Strongly in favor of 
1   2   3   4  5
  
 
3. Does your decision to undergo or not undergo prenatal genetic screening/testing agree with your 
feelings prior to the genetic counseling appointment? 
Yes 
No 
Additional comments:_______________ 
4. If this were a singleton pregnancy, what would your decision about prenatal genetic screening/ testing 
have been? 
Same         
Different   If different, in what way?:______________ 
I don’t know  
 
5. What factors influenced your decision-making? Choose all that apply: 
£ Partner/Spouse 
£ Other family member 
£ Doctor 
£ Genetic Counselor 
£ Religious beliefs  
£ Risk for pregnancy loss 
£ Chance of chromosome 
condition 
£ Cost 
£ Gaining reassurance about pregnancy 
£ Screening/testing in prior pregnancy 
£ Being pregnant with twins 
£ Difficulty becoming pregnant 
£ I don’t know  
£ None of the above 
£ Other:________________ 
___________________________________________________________________________ 
For Office Use Only: 
 
Date:___________ 
 
Age:______ G_____P_____  
 
Ethnicity: Caucasian   Hispanic 
Asian   African American
 Other:___________ 
 
ART?:   IVF  IUI   OI/Clomid 
PGS   PGD   Donor egg: Y/N 
Other:_______________ 
 
 
Offered Screens/Tests:   FTS  Quad  NIPT 
 CVS   Amnio 
 
Accepted Screens/Tests:  FTS   Quad  NIPT  
CVS   Amnio 
Indication:   Low Risk  
AMA  
Positive FTS  
Positive Quad Screen  
Positive Family History 
Positive Carrier Screen 
Ultrasound Abnormality
		 24		
APPENDIX B. 
Interview Guide 
Questions: 
• Tell me about your experience getting pregnant. 
o Probes 
§ What was your reaction to learning that you were pregnant with twins? 
§ Was this a positive or difficult experience? 
§ How did it affect your family and relationships? 
• Tell me about your experience with genetic counseling. 
o Probes 
§ What were your feelings toward/impressions of prenatal genetic 
screening and testing before the session? 
• Concerns? 
§ Did any prior feelings change after talking to the genetic counselor? 
• How? Why? 
§ Had you heard of prenatal genetic screening or testing prior to the 
appointment? 
• Did you pursue this option in a prior pregnancy? 
• Tell me about how you came to a decision about prenatal screening or testing. 
o Probes 
§ Do you think you would have felt the same way and made the same 
decision if this were a singleton pregnancy? 
§ Why did you choose______ over other options offered? 
§ What factors influenced your decision? 
§ Other than yourself, who played an important role in your decision? 
• Is there any other information you would like to share about carrying twins, having 
genetic counseling, screening or testing?
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